openPR Logo
Press release

United States Flu Vaccine Market & Forecast

08-07-2017 05:32 PM CET | Health & Medicine

Press release from: DPI Research

United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market.

Complete Report @ http://www.dpiresearch.com/report-details.php?P_ID=90

Major and Promising Vaccine covered in the report are as follows:

Fluzone High–Dose
Fluzone Quadrivalent
Intradermal (ID) Trivalent
Vaxigrip
Fluarix Quadrivalent
Flulaval Quadrivalent
Fluenz Tetra
FluMist Quadrivalent
Flublok
VN–100
M–001
VAX–2012Q
TAK – 850
Flucelvax Quadrivalent
Afluria Quadrivalent
Agrippal
Fluad
Fluvirin
Fluvax

Key Companies Covered in the Report are as follows:

Sanofi Pasteur
GlaxoSmithKline(GSK)
Seqirus
AstraZenecca
Protein Sciences Corporation
Novavax
Daiichi–Sankyo
Mitsubishi Tanabe Pharma
BiondVax Pharmaceuticals Ltd
VaxInnate

DPI Research is a business solutions firm which offer bespoke market research reports, custom research solutions and consulting across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.

DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Contact Us:
Maria Rai
Tel :+91 -7289949987
Email: sales@dpiresearch.com
Website: www.dpiresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Flu Vaccine Market & Forecast here

News-ID: 658451 • Views: 1125

More Releases from DPI Research

U.S. CGM Market Analysis Detailed Growth Outlook, New Developments, Upcoming Ind …
The United States Continuous Glucose Monitoring market analysis offered by DPI Research scrutinizes key growth factors that are impacting sales in the market. The report offers in-depth insights covering key factors such as drivers, opportunities, key players' strategies, and demand outlook for the CGM market. In addition to this, the study analyzes latest trends across various segments including product type and end use. Amid the COVID-19 crisis, the United States Continuous
United States Human Vaccines Market Worth US$ 31 Billion by 2028 | CAGR 7%
According to DPI Research Amid the COVID-19 crisis, the United States human vaccines market is poised to grow by US$ 31,517 million by 2028, accelerating at a CAGR of 7% during the forecast period. 𝗚𝗲𝘁 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗣𝗗𝗙 𝗦𝗮𝗺𝗽𝗹𝗲 𝗮𝘁- https://dpiresearch.com/request-a-free-sample-reports/ The prominent factors that are expected to contribute to the growth of the United States human vaccines market: Increased Disease Awareness Approval/launches of the New Vaccines Rising Focus on Immunization Programs Increasing Investments
South Korea E-Commerce Market and Forecast 2022 - 2028 | Exclusive Report by DPI …
DPI Research recently published a report, titled, "South Korea E-Commerce Market and Forecast 2022 - 2028" As per the report, "South Korea E-Commerce market size is expected to reach US$ 156 Billion by 2028" "South Korea E-Commerce Market and Forecast 2022 - 2028" provides a comprehensive analysis of the fast-evolving, high-growth e-commerce market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the

More Releases for Quadrivalent

Latest Quadrivalent Flu Vaccine Market Report- Size by Application | Sanofi Past …
The Quadrivalent Flu Vaccine Market research report market analysis puts a light on various segments that are relied upon to witness the quickest business development amid the estimated forecast frame CAGR levels for Quadrivalent Flu Vaccine Market concerning its rise or fall are evaluated in the report for the forecast period of 2021-2026. Furthermore, the Quadrivalent Flu Vaccine Market research report also analyses the market growth. Get FREE PDF Sample
Quadrivalent Flu Vaccine Market Analysis 2019 and Industry Insights in the Futur …
QY Research always aims at offering their clients an in-depth analysis and the best research material of the various market. This new report on the global Quadrivalent Flu Vaccine market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts. Request a Sample of this report at http://www.qyresearchglobal.com/goods-1899719.html Key Manufacturers:
Global Quadrivalent Flu Vaccine Market Expected to Witness a Sustainable Growth …
LP INFORMATION offers a latest published report on Quadrivalent Flu Vaccine Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Quadrivalent Flu Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Influenza Vaccine Market to See Worldwide Growth by 2025: Leading Companies Fluz …
A report added to the rich database of Qurate Business Intelligence, titled “Influenza Vaccine Market Size, Status and Forecast 2025”, provides a 360-degree overview of the worldwide market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the data reliable in context to
The U.S. Flu Vaccine Market Size and Outlook | Focus on Major Flu Vaccines such …
The U.S. Flu Vaccine Market Research Report Description: Ricerca Alfa, a leading market research firm recently collated a novel report on Flu Vaccine market. The report states that the Flu Vaccine Market is expected to reach approximately US$ 3 billion by the year 2024. The report also presents detailed key factors such as flu vaccine production, price, supply, demand, effectiveness, and many more. The research report encompasses current pricing trends (adult
Flu Vaccine Market to Surpass US$ 3 Bn by 2024 by Major Vaccines Fluzone High– …
A comprehensive report recently added to the excellent database of Qurate Business Intelligence, titled “Global Flu Vaccine Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 - 2017) and Future Forecast (2018 - 2024)”, provides an in – depth assessment of the market operating across various regions and countries. Estimations associated with the market values over the forecast period are based on pragmatic research and statistical data gathered through both